Navigation Links
Matuzumab in Medical News

Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab

Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab. Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale be...

Double binding sites on tumor target may provide future combination therapy

...r other types of cancer. An additional drug called matuzumab is in phase II clinical trials. Three years ago...s found again using X-ray crystallography -- that matuzumab binds in a different place from Erbitux. Their bin...has important implications for the clinical use of matuzumab and for developing new therapies that target EGFR....
Matuzumab in Medical Technology

ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting

...fferent anti-EGFR agents, including other monoclonal antibodies, have different biological effects. (#336 Meira et al. Differences in activity between matuzumab and cetuximab in A431 cells may rely on MAPK cascade inhibition.) -- Emerging biomarkers may serve as predictors of clinical response to ERBITUX. (#...
Matuzumab in other areas

Matuzumab - Wikipedia, the free encyclopedia

Matuzumab is a humanized monoclonal antibody for the treatment of cancer. It binds to EGFR with high affinity.

Matuzumab (EMD72000)

... please contact the site administrator at: matuzumab@emdpharmaceuticals.com. Matuzumab is currently under clinical investigation and has not been approved ...

Definition of matuzumab - National Cancer Institute Drug Dictionary

matuzumab. A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, ...

Definition of matuzumab - NCI Dictionary of Cancer Terms

matuzumab. A monoclonal antibody that is being studied in the treatment of ... Matuzumab binds to the epithelial growth factor receptor (EGFR) on tumor cells ...

Matuzumab facts - Freebase

Facts and figures about Matuzumab, taken from Freebase, the world's database. ... If you know more about Matuzumab, you can add more facts here " ...

Merck KGaA 'reconsidering' further development of Matuzumab in ...

FRANKFURT (Thomson Financial) - Merck KGaA said its division Merck Serono's Phase II trial of Matuzumab to treat metastatic colorectal cancer (mCRC) did not meet its ...
Other Tags
(Date:4/24/2014)... NH, 4/24/14) Dartmouth has been awarded one of ... serve as a Lead Academic Participating Site in its ... Award recipients are a select groups of investigators charged ... fewer cooperative groups., The NCTN grant system reflects recommendations ... It streamlines operations to achieve four goals:, ...
(Date:4/24/2014)... Orleans, LA The National Science Foundation has ... Research Experiences for Undergraduates (REU) Site grant in ... the training of undergraduates from diverse social and ... the New Orleans area. The project will ... the summers of 2014-16. It will be ...
(Date:4/24/2014)... research led by a scientist at the University of ... element in the development of the nervous system may ... breast cancer., A research team, led by Dr ... Department of Biology at York, has studied how voltage-gated ... These channels are found in the membranes of excitable ...
(Date:4/23/2014)... was safe and effective in treating patients with ... , according to a new pilot study published ... online. Known as fecal microbiota transplantation, the treatment ... or a nasogastric tube. The findings suggest approaches ... available to patients. , A growing concern, ...
(Date:4/23/2014)... Moffitt Cancer Center researchers say clinical trials for ... leukemia (AML) are very promising. Patients treated with ... and daunorubicin, are showing better responses than patients ... , "Acute myeloid leukemia is an aggressive ... success, especially in older patients," explained Jeffrey Lancet, ...
Breaking Medicine News(10 mins):Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Breast cancer replicates brain development process 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... 23 2014) A team of researchers ... (hNSCs) into the brains of nonhuman primates and ... 24 months found that the hNSCs had differentiated ... cause tumors. , The study will be published ... but is currently freely available on-line as ...
(Date:4/23/2014)... have found evidence of an interaction between prenatal ... behavior in children, especially in girls. , "The ... to prenatal smoking will have behavioral problems. ... Boutwell, Assistant Professor at Sam Houston State University, ... the study. "One possible explanation for this ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
Other Contents